文献速递脊柱脊髓外科神经重症

神经外科与心力衰竭的交汇:黄韧带与心肌组织野生型转甲状腺素蛋白淀粉样变伴双侧腕管综合征一例

Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome.
PubMed 文献 · World Neurosurg · 2019-07-29

本文报告一例71岁男性,数年间先后出现腰椎管狭窄、双侧腕管综合征和进行性心脏淀粉样变导致终末期心力衰竭,最终接受心脏移植,呈现ATTRwt淀粉样变的自然病史。作者提出黄韧带和屈肌腱鞘的病理评估可用于筛查有心脏淀粉样变和心衰风险的患者。

要点

  • ATTRwt淀粉样变可表现为腰椎管狭窄、腕管综合征和心力衰竭的临床三联征。
  • 心脏外症状(腕管综合征、腰椎管狭窄)可早于心衰症状数年出现。
  • 黄韧带和屈肌腱鞘病理评估或可筛查心脏淀粉样变高危患者。

核心结论

  • ATTRwt淀粉样变可表现为腰椎管狭窄、腕管综合征和心力衰竭的临床三联征,心脏外症状可先于心衰数年出现。
  • 对黄韧带和屈肌腱鞘进行病理评估,可能是筛查和治疗心脏淀粉样变及心衰高危人群的独特机会。

研究设计与样本

  • 单个病例报告,患者为71岁男性,数年间先后出现腰椎管狭窄、双侧腕管综合征和进行性心脏淀粉样变。

主要发现

  • 患者因进行性心脏淀粉样变导致终末期心力衰竭,最终接受心脏移植。
  • 腕管和腰椎症状在心力衰竭症状出现前数年即已表现。
  • 近期开发的药物已显示可减缓系统性及心脏淀粉样变的进展。

临床怎么用

  • 对接受脊柱或腕管手术的患者,可将黄韧带和屈肌腱鞘送病理评估,以筛查ATTRwt淀粉样变及心衰风险。
  • 识别腰椎管狭窄、腕管综合征与心衰三联征,有助于早期发现系统性淀粉样变。

局限性

  • 本文为单个病例报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transthyretin wild-type (ATTRwt) amyloidosis is a systemic process resulting in deposition of misfolded transthyretin protein in several different tissues throughout the body. It is known to be a cause of progressive, life-threatening cardiomyopathy and lumbar spinal stenosis and carpal tunnel syndrome. CASE DESCRIPTION: Here we present the case of a 71-year-old man who has clinical manifestations of all 3 entities over several years, providing a picture of the natural history of ATTRwt amyloidosis. This patient eventually underwent a heart transplant because of progressive cardiac amyloidosis (CA) resulting in end-stage heart failure. However, symptoms in carpal tunnel and lumbar spine manifested years before the symptoms of heart failure. ATTRwt amyloidosis may present as a clinical triad of lumbar stenosis, carpal tunnel syndrome, and heart failure. Recently developed medications have shown efficacy in slowing the progress of systemic and cardiac amyloidosis. CONCLUSIONS: Knowing that extracardiac symptoms may occur first, we propose that sending ligamentum flavum and flexor tenosynovium for pathologic evaluation may be a unique opportunity to screen and treat a population of patients at risk for developing CA and heart failure.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Dowd RS, Nail TJ, Arkun K, et al. Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome. World Neurosurg. 2019. PMID: 31369882. doi:10.1016/j.wneu.2019.07.172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。